Universitat Internacional de Catalunya
Administration and Management of Biomedical Companies
Other languages of instruction: Catalan, Spanish
Teaching staff
Questions will be resolved before or after class. To resolve non-face-to-face questions, they will be done by videoconference.
Introduction
The course is aimed at showing the key elements in the administration and management of biomedical companies. Throughout the course, the aspects that are introduced in the course "Entrepreneurship and Innovation" will be studied in depth and will focus even more on the biomedical company.
Pre-course requirements
Entrepreneurship and Innovation
Objectives
To know the key concepts for the strategic management of biomedical companies.
To know the key concepts of business finance.
To know the key concepts of marketing with special incidence in the development of the product.
To know the key concepts of commercial law.
Competences/Learning outcomes of the degree programme
CB1: That students have demonstrated to possess and understand knowledge in an area of study that starts from the base of general secondary education, and is usually found at a level that, although supported by advanced textbooks, also includes some aspects They involve knowledge coming from the cutting edge of your field of study.
CB3: That students have the ability to gather and interpret relevant data (usually within their study area) to make judgments that include a reflection on relevant issues of a social, scientific or ethical nature.
CB4: That students can transmit information, ideas, problems and solutions to both specialized and non-specialized audiences.
CG11: Recognizing basic concepts from different fields related to biomedical sciences.
CE19: Recognizing the principles of biomedical sciences related to health and learn to work in any field of Biomedical Sciences (biomedical company, bioinformatics laboratories, research laboratories, clinical analysis company, etc.
CT1: Developing the capacity for organization and planning appropriate to the moment.
CT3: Developing the capacity for analysis and synthesis.
Learning outcomes of the subject
At the end of the course, the student:
Uses information as a strategic tool in business management and technological development.
Demonstrates autonomy and critical sense in the interpretation of information.
Understands business management and administration strategies, knows how to use business plans as a work tool.
Learns about the different types of biomedical companies, including hospital management, biomedical startups, pharmaceutical companies and other types of service companies.
Knows the key concepts in the management of people in the biomedical field.
Knows the key principles of business finance.
Knows the key principles of marketing and, with a special incidence, the product development processes.
Knows the key principles that regulate commercial law.
Syllabus
-
Business strategy
-
Business plan
-
Canvas
-
Agile management (Lean, SCRUM, continuous improvement, etc.)
-
Human Resources
-
Finance
-
Accounting
-
Taxation
-
Financing
-
Business valuation
-
Marketing
-
Introduction
-
Promotion: segmentation and positioning
-
Pricing strategies
-
"Placement"
-
Product.
-
Commercial law
-
Corporate structure
-
Contract
-
Partners Agreement
-
Protection of intellectual property
Teaching and learning activities
In person
Lectures: 50-minute presentation of a theoretical topic by the teacher.
Clinical cases or case methods (CM): Approach to a real or imaginary situation. Students work on the questions formulated in small groups or in active interaction with the teacher and the answers are discussed. The teacher intervenes actively and, if necessary, contributes new knowledge.
Virtual education (EV): Online material that the student can consult from any computer, at any time and that will contribute to the self-learning of concepts related to the subject.
Evaluation systems and criteria
In person
Students in first call:
Class participation and attitude: 50%
Presentation of practical case: 50%
The Presentation of the practical case consists of a work carried out in groups of two or three students in which a listed company is chosen and the details of the company are analyzed and presented. From your business plans to the most financial aspects of the company.
Students in second or subsequent call: the continuous assessment mark will be saved.
The presentation of the practical case in the second call may only aspire to a maximum mark of 6 out of 10.
General points to keep in mind about the evaluation system:
To be able to do average, in the practical case presentation, a minimum grade of 5 must be obtained.
Attendance to case methods is mandatory.
Class participation is understood to be the contribution of interesting ideas or the raising of pertinent questions that help to improve the quality of the session, whether it is a lecture or case methods.
Attendance to the theoretical classes is not compulsory, but the assistants will have to be governed by the norms indicated by the professors. In case of not arriving on time, enter in silence without disturbing or interrupting the class. In case of not attending a minimum of 65%, participation in class will be scored in a very reduced way.
Bibliography and resources
-
The Enterpreneur’s Guide to a Biotech Startup. Peter Kolchinsky. www.evelexa.com . Free download: https://www.ctsi.ucla.edu/researcher-resources/files/view/docs/EGBS4_Kolchinsky.pdf
Evaluation period
- E1 25/04/2022 A13 16:00h